|
US2018116975A1
|
|
Compositions and combinations for the treatment of angiogenesis diseases and disorders
|
|
WO2010146585A1
|
|
Tellurium-containing compounds for treating viral infections
|
|
WO2010146547A1
|
|
Tellurium-containing compounds for facilitating transplantation
|
|
EP2385757A1
|
|
Tellurium-containing compounds for affecting male's fertility following chemotherapy and/or radiotherapy
|
|
EP2222167A2
|
|
Methods and compositions for inhibiting integrins using tellurium-containing compounds
|
|
US2007298124A1
|
|
Use of tellurium compounds for inhibition of interleukin-converting enzyme
|
|
CA2580805A1
|
|
Use of tellurium compounds as adjuvants
|
|
AU2004304716A1
|
|
Tellurium derivatives for prevention and treatment of neurodegenerative processes
|
|
AU2004246895A1
|
|
Methods of treating obesity and related disorders using tellurium and selenium compounds
|
|
IL146694D0
|
|
Use of an aqueous solution containing a biologically active complex of tellurium dioxide for manufacturing a medicament
|
